Literature DB >> 32306190

Gastroparesis and Severity of Delayed Gastric Emptying: Comparison of Patient Characteristics, Treatments and Medication Adverse Events.

Christopher M Navas1, Erica D Wadas2, Natalia H Zbib3, Michael D Crowell4, Brian E Lacy5.   

Abstract

BACKGROUND: Gastroparesis is a heterogeneous disorder. Patient characteristics and treatment responsiveness may differ based on the extent of delay in gastric emptying. AIMS: Characterize gastroparesis patients based on the degree of delay in gastric emptying, and assess the relationship of patient demographics, symptoms and response to therapy based on the extent of delay.
METHODS: 1333 solid-phase 4-h scintigraphic gastric emptying scans were reviewed. Delayed emptying was categorized on percent retention at 4 h: mild (10-19%), moderate (20-29%), and severe (≥ 30%). Analyses were performed with regard to demographics, symptoms, esophagogastroduodenoscopy findings, medication use, and emergency department (ED) visits/hospitalizations.
RESULTS: 284 patients had delayed gastric emptying: mild (42.6%), moderate (19.3%), and severe (37.3%). 79.5% were women, the mean age was 45 years (± 15), and mean symptom duration was 4.6 years (± 6.5). The main categories of gastroparesis were idiopathic and diabetes mellitus. The most commonly prescribed medications were metoclopramide, domperidone and erythromycin. Opiate use (n = 69) was associated with an increased degree of delayed gastric emptying (p = 0.03) with 50% of opiate users having very delayed gastric emptying. One-way analysis revealed that severely delayed gastric emptying correlated with both increased hospitalizations and ED visits.
CONCLUSIONS: Severe delay in gastric emptying is a risk factor for increased hospitalizations and ED visits. Opiate use correlates with increased severity of gastric emptying. Identifying at-risk patients, stopping opioids, and instituting a programmatic care plan for patients with severely delayed gastric emptying may reduce ED visits, hospitalizations, and healthcare costs.

Entities:  

Keywords:  Domperidone; ED visits; Gastric emptying; Gastroparesis; Hospitalizations; Opioids

Year:  2020        PMID: 32306190     DOI: 10.1007/s10620-020-06258-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  8 in total

1.  Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis.

Authors:  J P Guo; A H Maurer; R S Fisher; H P Parkman
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans.

Authors:  I D Jeong; M Camilleri; A Shin; J Iturrino; A Boldingh; I Busciglio; D Burton; M Ryks; D Rhoten; A R Zinsmeister
Journal:  Aliment Pharmacol Ther       Date:  2012-02-21       Impact factor: 8.171

3.  The Burdens, Concerns, and Quality of Life of Patients with Gastroparesis.

Authors:  Daohai Yu; Frederick V Ramsey; William F Norton; Nancy Norton; Susan Schneck; Tegan Gaetano; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2017-01-21       Impact factor: 3.199

Review 4.  Gastroparesis: Medical and Therapeutic Advances.

Authors:  Christopher M Navas; Nihal K Patel; Brian E Lacy
Journal:  Dig Dis Sci       Date:  2017-07-18       Impact factor: 3.199

5.  Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis.

Authors:  I Soykan; B Sivri; I Sarosiek; B Kiernan; R W McCallum
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

6.  Gastric emptying in patients with insulin-requiring diabetes mellitus.

Authors:  A Keshavarzian; F L Iber; J Vaeth
Journal:  Am J Gastroenterol       Date:  1987-01       Impact factor: 10.864

7.  Effects of morphine and naloxone on esophageal motility and gastric emptying in man.

Authors:  R K Mittal; E B Frank; R C Lange; R W McCallum
Journal:  Dig Dis Sci       Date:  1986-09       Impact factor: 3.199

8.  Inflammatory causes of gastroparesis: report of five cases.

Authors:  H Pande; B E Lacy; M D Crowell
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.487

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.